Judy Berlfein
Biogen (United States)(US)
Publications by Year
Research Areas
Lymphoma Diagnosis and Treatment, Monoclonal and Polyclonal Antibodies Research, Radiopharmaceutical Chemistry and Applications, Viral-associated cancers and disorders, Blood Coagulation and Thrombosis Mechanisms
Most-Cited Works
- → Prolonged Clinical and Molecular Remission in Patients With Low-Grade or Follicular Non-Hodgkin's Lymphoma Treated With Rituximab Plus CHOP Chemotherapy: 9-Year Follow-Up(2004)364 cited
- → Phase I/II 90 Y-Zevalin (yttrium-90 ibritumomab tiuxetan, IDEC-Y2B8) radioimmunotherapy dosimetry results in relapsed or refractory non-Hodgkin's lymphoma(2000)234 cited
- → Antibody-Targeted Immunotherapy for Treatment of Non-Hodgkins Lymphoma(2000)15 cited
- → Recombinant Factor VIII– and Factor IX–Fc Fusions(2013)1 cited
- → A first step, but still a long way to go(1991)